<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02854098</url>
  </required_header>
  <id_info>
    <org_study_id>1W33</org_study_id>
    <nct_id>NCT02854098</nct_id>
  </id_info>
  <brief_title>The Comorbidity of Benign Hypermobility Joint Syndrome and Functional Constipation in Children</brief_title>
  <acronym>MobCon</acronym>
  <official_title>The Comorbidity of Benign Hypermobility Joint Syndrome and Functional Constipation in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Benign Hypermobility Joint Syndrome is a group of inherited abnormalities in the structure of&#xD;
      connective tissues, manifested by disturbances in the proportion of collagen. The main&#xD;
      symptoms of this syndrome include: laxity of joint capsules and ligaments, hypermobility of&#xD;
      the joints, as well as numerous disturbances in the functioning of internal organs that&#xD;
      contain connective tissue, including the gastrointestinal tract. Hypermobility of joints&#xD;
      affects approximately 10% of the population of Western countries, is more common in small&#xD;
      children and female. Modified Beighton scale is the basic scale for assessing hypermobility&#xD;
      of joints. The scale (as assessed using the goniometer) is a reliable tool for the evaluation&#xD;
      of excessive laxity of the connective tissue in children.&#xD;
&#xD;
      Functional constipation is a very common condition, affecting approximately 3-5% of children&#xD;
      and adolescents, with peak onset between 2 and 4 years of age. The etiology of this disorder&#xD;
      is multifactorial, and till day it is still exactly unknown why some children develop&#xD;
      constipation, while in others we can observe the correct scheme of defecation. Suspending&#xD;
      stool enhances the retention of fecal masses, which subsequently causes painful defecation.&#xD;
      Diagnosis is based on history, clinical symptoms and physical examination. Increased&#xD;
      susceptibility of the wall of the distal gastrointestinal tract could explain the&#xD;
      predisposition of some children to retain fecal masses and the development of constipation.&#xD;
&#xD;
      Due to the unclear etiology of functional constipation, it seems reasonable to conduct a&#xD;
      study assessing whether excessive laxity of connective tissue (assessed on the basis of the&#xD;
      hypermobility of the joints) facilitates the accumulation of stool in the large intestine,&#xD;
      and so is the one of the reasons leading to development of functional constipation in&#xD;
      children.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical question: Is there among patients with functional constipation increased percentage&#xD;
      of children with Benign Hypermobility Joint Syndrome, compared with a population of healthy&#xD;
      children? In discussion we would like to determine whether the excessive laxity of connective&#xD;
      tissue can promote the development of functional constipation in children.&#xD;
&#xD;
      Description of the study:&#xD;
&#xD;
        1. Anamnesis and physical examination of the patient&#xD;
&#xD;
        2. The consent of the parents and the patient (if &gt; 15 years) to participate in the study&#xD;
&#xD;
        3. Determining whether the patient meets the criteria for inclusion in the study&#xD;
&#xD;
        4. The exclusion of patients meeting the exclusion criteria for the study - on the basis of&#xD;
           anamnesis and physical examination (including neurological) and diagnostic tests&#xD;
           (biochemical and electrolyte TSH -, Na, K, Ca, P, Mg), if indicated&#xD;
&#xD;
        5. In patients classified to the study, the degree of laxity of the connective tissue will&#xD;
           be assessed in the basis of modified Beighton scale&#xD;
&#xD;
        6. In the control group - patients without constipation in an interview - the degree of&#xD;
           laxity of the connective tissue will be assessed in the basis of modified Beighton scale&#xD;
&#xD;
        7. Evaluation of the results.&#xD;
&#xD;
      Rome III Criteria Functional Constipation&#xD;
&#xD;
      Diagnostic criteria must include one month in children up to 4 years of age and two months in&#xD;
      older children(with insufficient criteria for diagnosis of IBS) of at least two of the&#xD;
      following:&#xD;
&#xD;
        1. Two or fewer defecations per week&#xD;
&#xD;
        2. At least one episode/week of incontinence after the acquisition of toileting skills&#xD;
&#xD;
        3. History of excessive stool retention&#xD;
&#xD;
        4. History of painful or hard bowel movements&#xD;
&#xD;
        5. Presence of a large fecal mass in the rectum&#xD;
&#xD;
        6. History of large diameter stools which may obstruct the toilet Accompanying symptoms may&#xD;
           include irritability, decreased appetite, and/or early satiety. The accompanying&#xD;
           symptoms disappear immediately following passage of a large stool.&#xD;
&#xD;
      Modified Beighton scale Hypermobility of joints indicates ≥ 4 points out of 9 possible.&#xD;
&#xD;
      The Beighton score is measured by adding 1 point for each of the following:&#xD;
&#xD;
        1. Placing flat hands on the floor with straight legs&#xD;
&#xD;
        2. Left knee bending backward (&gt;10 °)&#xD;
&#xD;
        3. Right knee bending backward (&gt;10 °)&#xD;
&#xD;
        4. Left elbow bending backward (&gt;10 °)&#xD;
&#xD;
        5. Right elbow bending backward (&gt;10 °)&#xD;
&#xD;
        6. Left thumb touching the forearm&#xD;
&#xD;
        7. Right thumb touching the forearm&#xD;
&#xD;
        8. Left little finger bending backward (&gt;90 °)&#xD;
&#xD;
        9. Right little finger bending backward (&gt;90 °)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>The comorbidity of benign hypermobility joint syndrome and functional constipation in children (in %)</measure>
    <time_frame>April 2017</time_frame>
    <description>The Hypermobility of the connective tissue as one of the etiological factors of functional constipation in children</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The comorbidity of BHJS and functional constipation, depending on age (in %)</measure>
    <time_frame>April 2017</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The comorbidity of BHJS and functional constipation, depending on gender (in %)</measure>
    <time_frame>April 2017</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Benign Hypermobility Syndrome</condition>
  <condition>Functional Constipation</condition>
  <arm_group>
    <arm_group_label>with functional constipation</arm_group_label>
    <description>n = 200 patients with functional constipation examined for BHJS age 3 -18 years meet inclusion criteria, do not fulfill exclusion criteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without functional constipation</arm_group_label>
    <description>n = 200 patient with functional constipation examined for BHJS age 3 -18 years meet inclusion criteria, do not fulfill exclusion criteria</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        2 groups, n = 400 (200 patients each group) age 3 - 18 years. first group - with functional&#xD;
        constipation second group - without functional constipation&#xD;
&#xD;
        Each patient meet inclusion criteria, do not fulfill exclusion criteria&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        First group:&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 3 - 18 years.&#xD;
&#xD;
          2. Diagnosed functional constipation (on the basis of III Rome Criteria)&#xD;
&#xD;
          3. Informed consent of patients (if more than 16 years) and caregivers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Organic causes of constipation (anatomical abnormalities: narrowing of the anus or&#xD;
             rectum, state after surgical correction of this anomalies)&#xD;
&#xD;
          2. Metabolic and gastrological diseases in anamnesis: hypothyroidism, hypercalcemia,&#xD;
             hypokalemia, cystic fibrosis, diabetes, celiac disease&#xD;
&#xD;
          3. Neuropathies: defects and injures of the spinal cord, encephalopathies&#xD;
&#xD;
          4. Neuromuscular disorders: Hirschsprung's disease, intestinal neuronal dysplasia,&#xD;
             visceral myopathies and neuropathies&#xD;
&#xD;
          5. Abnormal abdominal musculature: Down syndrome;&#xD;
&#xD;
          6. The use of drugs (opioids, phenobarbital, sucralfate, antidepressants,&#xD;
             anticholinergic, sympathomimetic)&#xD;
&#xD;
          7. Lack of informed consent of patients (if more than 16 years) and caregivers&#xD;
&#xD;
        Second group:&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 3 - 18 years.&#xD;
&#xD;
          2. Without functional constipation&#xD;
&#xD;
          3. Informed consent of patients and caregivers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1 Lack of informed consent of patients and caregivers&#xD;
&#xD;
        Place: Department of Pediatric Gastroenterology and Nutrition, Medical University of&#xD;
        Warsaw, Poland&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Piotr Albrecht, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrzej Załęski, MD</last_name>
    <phone>+48 600 982 185</phone>
    <email>andrzejzaleski84@wp.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Agnieszka Gawrońska, PhD</last_name>
    <phone>+48 22 317 94 51</phone>
    <email>gastroenterologia@spdsk.edu.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <state>Mazowieckie</state>
        <zip>02-091</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrzej Załęski, MD</last_name>
      <phone>+ 48 600982185</phone>
      <email>andrzejzaleski84@wp.pl</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <link>
    <url>http://romecriteria.org</url>
    <description>Rome III Criteria</description>
  </link>
  <reference>
    <citation>Mirska A, Kalinowska AK, Topór E, et al. Łagodny zespół hipermobilności stawów (BHJS). Neurologia Dziecięca 2011; 41; 135-140.</citation>
  </reference>
  <reference>
    <citation>Kovacic K, Chelimsky TC, Sood MR, Simpson P, Nugent M, Chelimsky G. Joint hypermobility: a common association with complex functional gastrointestinal disorders. J Pediatr. 2014 Nov;165(5):973-8. doi: 10.1016/j.jpeds.2014.07.021. Epub 2014 Aug 20.</citation>
    <PMID>25151198</PMID>
  </reference>
  <reference>
    <citation>Fikree A, Grahame R, Aktar R, Farmer AD, Hakim AJ, Morris JK, Knowles CH, Aziz Q. A prospective evaluation of undiagnosed joint hypermobility syndrome in patients with gastrointestinal symptoms. Clin Gastroenterol Hepatol. 2014 Oct;12(10):1680-87.e2. doi: 10.1016/j.cgh.2014.01.014. Epub 2014 Jan 16.</citation>
    <PMID>24440216</PMID>
  </reference>
  <reference>
    <citation>Grahame R, Bird HA, Child A. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol. 2000 Jul;27(7):1777-9.</citation>
    <PMID>10914867</PMID>
  </reference>
  <reference>
    <citation>Smits-Engelsman B, Klerks M, Kirby A. Beighton score: a valid measure for generalized hypermobility in children. J Pediatr. 2011 Jan;158(1):119-23, 123.e1-4. doi: 10.1016/j.jpeds.2010.07.021. Epub 2010 Sep 17.</citation>
    <PMID>20850761</PMID>
  </reference>
  <reference>
    <citation>Zarate N, Farmer AD, Grahame R, Mohammed SD, Knowles CH, Scott SM, Aziz Q. Unexplained gastrointestinal symptoms and joint hypermobility: is connective tissue the missing link? Neurogastroenterol Motil. 2010 Mar;22(3):252-e78. doi: 10.1111/j.1365-2982.2009.01421.x. Epub 2009 Oct 15.</citation>
    <PMID>19840271</PMID>
  </reference>
  <reference>
    <citation>Mohammed SD, Lunniss PJ, Zarate N, Farmer AD, Grahame R, Aziz Q, Scott SM. Joint hypermobility and rectal evacuatory dysfunction: an etiological link in abnormal connective tissue? Neurogastroenterol Motil. 2010 Oct;22(10):1085-e283. doi: 10.1111/j.1365-2982.2010.01562.x. Epub 2010 Jul 5.</citation>
    <PMID>20618831</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <study_first_submitted>July 16, 2016</study_first_submitted>
  <study_first_submitted_qc>July 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2016</study_first_posted>
  <last_update_submitted>March 29, 2017</last_update_submitted>
  <last_update_submitted_qc>March 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Warsaw</investigator_affiliation>
    <investigator_full_name>Andrzej Załęski</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>BHJS, constipation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

